ScreenerHero

ADO AnteoTech Limited

ASX · AU · Healthcare · Biotechnology · anteotech.com
—Mkt Cap: —P/E: —

AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. The company's products incl…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.87BUSDP/E 29.6
MRNA
Moderna, Inc.
$94.42BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$81.99BUSDP/E 19.1
ARGX
argenx SE
$53.47BUSDP/E 32.5
ARGX
argenx SE
$53.22BUSDP/E 31.6
UCB
UCB SA
$44.02BUSDP/E 17.8
ONC
BeOne Medicines AG
$42.56BUSDP/E 66.4
RVMD
Revolution Medicines, Inc.
$40.57BUSD
RPRX
Royalty Pharma plc
$34.45BUSDP/E 30.4
ALNY
Alnylam Pharmaceuticals, Inc.
$31.32BUSDP/E 39.3
ROIV
Roivant Sciences Ltd.
$24.59BUSD
GMAB
Genmab A/S
$23.32BUSDP/E 31.7
GMAB
Genmab A/S
$23.26BUSDP/E 29.8
INCY
Incyte Corporation
$22.96BUSDP/E 14.0
BNTX
BioNTech SE
$22.66BUSD
INSM
Insmed Incorporated
$21.67BUSD
EXEL
Exelixis, Inc.
$15.57BUSDP/E 19.3
ASND
Ascendis Pharma A/S
$14.91BUSDP/E 17.4
JAZZ
Jazz Pharmaceuticals plc
$13.92BUSDP/E 14.7
HALO
Halozyme Therapeutics, Inc.
$13.79BUSDP/E 33.4

Key Statistics

Company
Market Cap—
Enterprise Value27.53M USD
Revenue (TTM)323.14K USD
Gross Profit669.58K USD
Net Income (TTM)-4.67M USD
Revenue/Share0.00 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU000000ADO8
Valuation
P/E (Trailing)—
P/E (Forward)-15.00
PEG—
EV/EBITDA-7.96
EV/Revenue85.21
P/S104.74
P/B5.00
EPS (TTM)0.00
EPS (Forward)-0.00
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin100.00%
Oper. Margin-1085.08%
EBITDA Margin0.00%
Profit Margin-697.62%
ROE-214.56%
ROA-104.84%
Growth
Revenue Growth20.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.75M USD
CapEx (TTM)152.27K USD
FCF Margin-355.04%
FCF Yield—
Net Debt-6.26M USD
Net Debt/EBITDA1.81
Balance Sheet
Debt/Equity0.62
Current Ratio8.09
Quick Ratio7.94
Book Value/Sh0.0030 AUD
Cash/Share0.0030 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateSep 26, 2005
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)0.0820 AUD
Target Range0.0820 AUD – 0.0820 AUD
# Analysts1
Ownership
Shares Out.3.27B
Float2.87B
Insiders13.35%
Institutions0.00%
Technical
SMA 500.0183 AUD
SMA 2000.0185 AUD
Beta1.34
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)1.57M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—